Compare Neurocrine Biosciences Inc (NBIX) vs Payoneer Global Inc (PAYO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Payoneer Global Inc — how do they compare? Neurocrine Biosciences Inc trades at $152.5 (market cap $16.46B), while Payoneer Global Inc trades at $7.08 (market cap $2.40B). The key difference: Neurocrine Biosciences Inc is far larger — about 6.9× Payoneer Global Inc's market cap, and Payoneer Global Inc is trading nearer its 52-week high, Neurocrine Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| NBIX | PAYO | |
|---|---|---|
Market Cap | $16.46B | $2.40B |
Sector | Health | Technology |
52-Week High | $185.50 | $7.17 |
52-Week Low | $123.10 | $4.27 |
Enterprise Value | $16.48B | $2.14B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Payoneer Global Inc. (PAYO) trades at $7.09, down 0.14% on the day, near its 52-week high of $7.67. The stock shows a bullish technical signal with strong moving averages, while fundamentals reveal mixed earnings with Q2 2026 EPS missing estimates at $0.02 versus $0.06 expected. Revenue growth remains solid, up 10% year-over-year excluding interest in Q2 2026. Sentiment is influenced by the pending acquisition by Nuvei for $7.40 per share, announced on June 15, 2026, which has sparked legal inquiries over fairness.
The outlook is cautiously optimistic with a consensus price target of $8.20 offering 16% upside, but risks include integration challenges from the Nuvei deal and earnings volatility. Investors should weigh the acquisition premium against potential shareholder litigation and execution risks in cross-border payment growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Payoneer Global Inc
Payoneer Global Inc is the world's go-to partner for digital commerce, everywhere. The company started as a cross-border payments platform that empowers businesses, online sellers, and freelancers. The platform allows the users to get paid in multiple currencies, bill global clients, and sell on marketplaces worldwide.
Read more on PAYO →
